the portion of hno2-susceptible glycosaminoglycans ( heparan sulfate ) decreases whereas that of chondroitin abc-lyase digestible material ( chondroitin sulfate , dermatan sulfate ) increases .
C0017973
glycosaminoglycans
C0019143
heparan sulfate